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Abstract
On the basis of their biological function, potential genetic
candidates for susceptibility to rheumatoid arthritis can be
postulated. IFNGR1, encoding the ligand-binding chain of the
receptor for interferon gamma, IFNγR1, is one such gene
because interferon gamma is involved in the pathogenesis of the
disease. In the coding sequence of IFNGR1, two nucleotide
positions have been described to be polymorphic in the
Japanese population. We therefore investigated the association
of those two IFNGR1  single nucleotide polymorphisms with
rheumatoid arthritis in a case-control study in a central European
population. Surprisingly, however, neither position was
polymorphic in the 364 individuals examined, indicating that
IFNGR1  does not contribute to susceptibility to rheumatoid
arthritis, at least in Caucasians.
Introduction
Many pathologic autoimmune responses are characterized by
an imbalance in the T helper type (Th) 1/Th2 ratio in favor of
the former [1]. As activated Th1 cells mediate their functions
via their signature cytokine, interferon gamma (IFNγ), the inter-
feron gamma receptor (IFNγR) plays an important role in the
pathogenesis of these diseases by transmitting IFNγ signaling.
The IFNγR consists of the ligand-binding chain IFNγR1 and the
signal-transducing chain IFNγR2. Within the coding region of
the IFGR1 gene [GeneBank accession number NM_000416],
two single nucleotide polymorphisms (SNPs) (40 C/T and
1,400 T/C) that result in the amino acid substitutions valine to
methionine at position 14 (V467M) and leucine to proline at
position 467 (L467P), respectively, have been identified in the
Japanese population [2,3].
Th1 cells have been implicated in many aspects of the patho-
genesis of rheumatoid arthritis (RA) [1]. Evidence suggests
that both genetic and environmental factors contribute to the
development of rheumatoid inflammation [4-6]. Elucidating the
genetic basis of RA, however, is still one of the major chal-
lenges in modern rheumatology. The identification of RA sus-
ceptibility genes has been difficult because RA is a complex
autoimmune disease that, unlike classic Mendelian traits caus-
ally related to highly penetrant rare mutations of single genes,
appears to be caused by small individual effects of many
poorly penetrant common alleles.
The association of the two IFNGR1 SNPs 40 C/T and 1,400
T/C with susceptibility to immune disorders mediated by an
imbalance in the Th1/Th2 ratio has recently been demon-
strated in Japanese cohorts; for example, in allergy [2] and in
systemic lupus erythematosis [3,7]. Because of the potential
importance of IFNGR1 SNPs in immunity in health and dis-
ease in people of all ethnic origins, these observations
prompted us to perform a case-control association study to
investigate the role of both IFNGR1 SNPs in susceptibility to
RA, a Th1-mediated autoimmune disease, in a Caucasian pop-
ulation.
IFNγ = interferon gamma; IFNγR = interferon gamma receptor; PCR = polymerase chain reaction; RA = rheumatoid arthritis; SNP = single nucleotide 
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Materials and methods
One hundred and one patients with an established diagnosis
of RA, according to the 1987 revised criteria of the American
College of Rheumatology for the classification of the disease,
were enrolled in the study. The 101 patients represented an
ethnically homogeneous cohort of Caucasian RA patients. The
median (range) age of the patients at time of the analysis was
63 years (17–81 years), and 76% were female. A cohort of
171 healthy individuals matched on the basis of age, sex and
origin were used as a healthy control group. All protocols and
recruitment sites have been approved by the local institutional
review boards, and all subjects were enrolled with informed
written consent.
Genomic DNA was isolated from white blood cells using the
AquaPure Genomic DNA isolation kit (BioRad Laboratories,
Munich, Germany). Genotype analysis was performed by
allele-specific PCR and verified by direct sequencing. PCR
primer and probe sequences for the V14M SNP were 5' -AGT-
GGAGTGGCTACAAAGGTCCC-3' (forward primer) and 5' -
CCCATCTCAGCCCTGCTCAC/T-3' (reverse primer). PCR
primer and probe sequences for the L467P SNP were 5' -
CATGTGCTAGTGGATCTACT/C-3' (forward primer) and 5' -
AGTGGAGTGGCTACAAAGGTCCC-3' (reverse primer).
Results and discussion
In marked contrast to previous findings, no polymorphic alleles
(neither thymine at position 40 nor cytosine at position 1,400)
were detected in any of the individuals tested. This was sur-
prising because both positions were highly polymorphic in the
original publications. In those publications, heterozygosity at
position 40 (V14M) was detected in four individuals (4.4%) in
a small cohort of 91 healthy controls and even in 15 out of 96
(15.6%) lupus patients [7], and heterozygosity at position
1,400 (L467P) was detected in four individuals (6.7%) in a
cohort of 89 allergic patients, although it was absent in healthy
controls [2].
To verify our results for position 1,400, therefore, we addition-
ally analyzed genomic DNA of 82 well-characterized atopic
patients with an established clinically relevant type I allergy
directed, for example, to house dust, mite, birch pollen or bee
venom. However, this population was not polymorphic at
either of the two positions either. Our data therefore strongly
suggest that the IFNG1R gene is not polymorphic at those
two positions at least among Caucasians and therefore does
not contribute to genetic susceptibility to RA.
Some ethnic variations in the frequencies of SNPs linked to
RA have been already reported [8]. Analysis of RA-associated
SNPs in solute carrier family 22 members 4 and 5 (SLC22A4
and  SLC22A5) [9] and in protein tyrosine phosphatase
(PTPN22) [10] in different ethnic groups revealed that the dis-
ease-associated polymorphic alleles usually common in Cau-
casians (over 8% prevalence) are absent or only extremely
rarely present in the Japanese population [8]. Our data are in
line with these observations and together implicate that asso-
ciation findings should be carefully analyzed in different ethnic
contexts to allow meaningful conclusions regarding whether
the gene of interest is of importance in the susceptibility to a
particular autoimmune disease.
Conclusion
IFNGR1 is not polymorphic in Caucasians although it is poly-
morphic in the Japanese population. It is therefore unlikely to
contribute to susceptibility to RA, at least in Caucasian
cohorts of patients.
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